John W. Wills All publications ( 63 ) Baird NL. Yeh PC. Courtney RJ. Wills JW. Sequences in the UL11 tegument protein of herpes simplex virus that control association with detergent-resistant membranes. 2008 May 10. Virology. 374(2):315-21. Meckes DG. Wills JW. Structural Rearrangement within an Enveloped Virus upon Binding to the Host Cell. 2008 Aug 20. J Virol. . Yeh PC. Meckes DG. Wills JW. Analysis of the Interaction between the UL11 and UL16 Tegument Proteins of Herpes Simplex Virus. 2008 Aug 20. J Virol. . Bucks MA. O'Regan KJ. Murphy MA. Wills JW. Courtney RJ. Herpes simplex virus type 1 tegument proteins VP1/2 and UL37 are associated with intranuclear capsids. 2007 May 10. Virology. 361(2):316-24. National Cancer Institute O'Regan KJ. Bucks MA. Murphy MA. Wills JW. Courtney RJ. A conserved region of the herpes simplex virus type 1 tegument protein VP22 facilitates interaction with the cytoplasmic tail of glycoprotein E (gE). 2007 Feb 5. Virology. 358(1):192-200. National Cancer Institute Spidel JL. Wilson CB. Craven RC. Wills JW. Genetic Studies of the beta-hairpin loop of Rous sarcoma virus capsid protein. 2007 Feb. J Virol. 81(3):1288-96. National Cancer Institute O'Regan KJ. Murphy MA. Bucks MA. Wills JW. Courtney RJ. Incorporation of the herpes simplex virus type 1 tegument protein VP22 into the virus particle is independent of interaction with VP16. 2007 Dec 20. Virology. 369(2):263-80. Meckes DG. Wills JW. Dynamic interactions of the UL16 tegument protein with the capsid of herpes simplex virus. 2007 Dec. J Virol. 81(23):13028-36. Loomis JS. Courtney RJ. Wills JW. Packaging determinants in the UL11 tegument protein of herpes simplex virus type 1. 2006 Nov. J Virol. 80(21):10534-41. National Cancer Institute Spidel JL. Craven RC. Wilson CB. Patnaik A. Wang H. Mansky LM. Wills JW. Lysines close to the Rous sarcoma virus late domain critical for budding. 2004 Oct. J Virol. 78(19):10606-16. National Institute of Allergy and Infectious Diseases National Cancer Institute Callahan EM. Wills JW. Link between genome packaging and rate of budding for Rous sarcoma virus. 2003 Sep. J Virol. 77(17):9388-98. National Cancer Institute Loomis JS. Courtney RJ. Wills JW. Binding partners for the UL11 tegument protein of herpes simplex virus type 1. 2003 Nov. J Virol. 77(21):11417-24. National Cancer Institute Brignati MJ. Loomis JS. Wills JW. Courtney RJ. Membrane association of VP22, a herpes simplex virus type 1 tegument protein. 2003 Apr. J Virol. 77(8):4888-98. National Cancer Institute Patnaik A. Wills JW. In vivo interference of Rous sarcoma virus budding by cis expression of a WW domain. 2002 Mar. J Virol. 76(6):2789-95. National Cancer Institute Patnaik A. Chau V. Li F. Montelaro RC. Wills JW. Budding of equine infectious anemia virus is insensitive to proteasome inhibitors. 2002 Mar. J Virol. 76(6):2641-7. National Cancer Institute Krishna NK. Wills JW. Insertion of capsid proteins from nonenveloped viruses into the retroviral budding pathway. 2001 Jul. J Virol. 75(14):6527-36. National Cancer Institute Loomis JS. Bowzard JB. Courtney RJ. Wills JW. Intracellular trafficking of the UL11 tegument protein of herpes simplex virus type 1. 2001 Dec. J Virol. 75(24):12209-19. National Cancer Institute Bowzard JB. Wills JW. Craven RC. Second-site suppressors of Rous sarcoma virus Ca mutations: evidence for interdomain interactions. 2001 Aug. J Virol. 75(15):6850-6. National Cancer Institute Bowzard JB. Visalli RJ. Wilson CB. Loomis JS. Callahan EM. Courtney RJ. Wills JW. Membrane targeting properties of a herpesvirus tegument protein-retrovirus Gag chimera. 2000 Sep. J Virol. 74(18):8692-9. National Cancer Institute Patnaik A. Chau V. Wills JW. Ubiquitin is part of the retrovirus budding machinery. 2000 Nov 21. Proc Natl Acad Sci U S A. 97(24):13069-74. National Cancer Institute Parent LJ. Cairns TM. Albert JA. Wilson CB. Wills JW. Craven RC. RNA dimerization defect in a Rous sarcoma virus matrix mutant. 2000 Jan. J Virol. 74(1):164-72. National Institute of Allergy and Infectious Diseases National Cancer Institute Callahan EM. Wills JW. Repositioning basic residues in the M domain of the Rous sarcoma virus gag protein. 2000 Dec. J Virol. 74(23):11222-9. National Cancer Institute Garnier L. Parent LJ. Rovinski B. Cao SX. Wills JW. Identification of retroviral late domains as determinants of particle size. 1999 Mar. J Virol. 73(3):2309-20. National Institute of Allergy and Infectious Diseases National Cancer Institute Bennett RP. Wills JW. Conditions for copackaging rous sarcoma virus and murine leukemia virus Gag proteins during retroviral budding. 1999 Mar. J Virol. 73(3):2045-51. National Cancer Institute Craven RC. Harty RN. Paragas J. Palese P. Wills JW. Late domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimeras. 1999 Apr. J Virol. 73(4):3359-65. National Cancer Institute Bowzard JB. Bennett RP. Krishna NK. Ernst SM. Rein A. Wills JW. Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue. 1998 Nov. J Virol. 72(11):9034-44. National Cancer Institute Garnier L. Ratner L. Rovinski B. Cao SX. Wills JW. Particle size determinants in the human immunodeficiency virus type 1 Gag protein. 1998 Jun. J Virol. 72(6):4667-77. National Institute of Allergy and Infectious Diseases National Cancer Institute Krishna NK. Campbell S. Vogt VM. Wills JW. Genetic determinants of Rous sarcoma virus particle size. 1998 Jan. J Virol. 72(1):564-77. National Cancer Institute Nelle TD. Verderame MF. Leis J. Wills JW. The major site of phosphorylation within the Rous sarcoma virus MA protein is not required for replication. 1998 Feb. J Virol. 72(2):1103-7. National Cancer Institute Garnier L. Bowzard JB. Wills JW. Recent advances and remaining problems in HIV assembly. 1998. AIDS. 12 Suppl A:S5-16. National Cancer Institute Puffer BA. Parent LJ. Wills JW. Montelaro RC. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. 1997 Sep. J Virol. 71(9):6541-6. National Cancer Institute Public Health Service Krishna NK. Weldon RA. Wills JW. Transport and processing of the Rous sarcoma virus Gag protein in the endoplasmic reticulum. 1996 Mar. J Virol. 70(3):1570-9. National Cancer Institute Garnier L. Wills JW. Verderame MF. Sudol M. WW domains and retrovirus budding. 1996 Jun 27. Nature. 381(6585):744-5. Parent LJ. Wilson CB. Resh MD. Wills JW. Evidence for a second function of the MA sequence in the Rous sarcoma virus Gag protein. 1996 Feb. J Virol. 70(2):1016-26. National Cancer Institute National Institute of Allergy and Infectious Diseases Xiang Y. Cameron CE. Wills JW. Leis J. Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain. 1996 Aug. J Virol. 70(8):5695-700. National Cancer Institute Verderame MF. Nelle TD. Wills JW. The membrane-binding domain of the Rous sarcoma virus Gag protein. 1996 Apr. J Virol. 70(4):2664-8. National Cancer Institute Nelle TD. Wills JW. A large region within the Rous sarcoma virus matrix protein is dispensable for budding and infectivity. 1996 Apr. J Virol. 70(4):2269-76. National Cancer Institute Parent LJ. Bennett RP. Craven RC. Nelle TD. Krishna NK. Bowzard JB. Wilson CB. Puffer BA. Montelaro RC. Wills JW. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. 1995 Sep. J Virol. 69(9):5455-60. National Institute of Allergy and Infectious Diseases National Cancer Institute Lu YL. Bennett RP. Wills JW. Gorelick R. Ratner L. A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles. 1995 Nov. J Virol. 69(11):6873-9. National Institute of Allergy and Infectious Diseases National Cancer Institute Craven RC. Leure-duPree AE. Weldon RA. Wills JW. Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein. 1995 Jul. J Virol. 69(7):4213-27. National Cancer Institute Pan W. Craven RC. Qiu Q. Wilson CB. Wills JW. Golovine S. Wang JF. Isolation of virus-neutralizing RNAs from a large pool of random sequences. 1995 Dec 5. Proc Natl Acad Sci U S A. 92(25):11509-13. National Cancer Institute Sakalian M. Wills JW. Vogt VM. Efficiency and selectivity of RNA packaging by Rous sarcoma virus Gag deletion mutants. 1994 Sep. J Virol. 68(9):5969-81. National Cancer Institute Wills JW. Cameron CE. Wilson CB. Xiang Y. Bennett RP. Leis J. An assembly domain of the Rous sarcoma virus Gag protein required late in budding. 1994 Oct. J Virol. 68(10):6605-18. National Cancer Institute Zhou W. Parent LJ. Wills JW. Resh MD. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. 1994 Apr. J Virol. 68(4):2556-69. National Cancer Institute National Institute of Allergy and Infectious Diseases Weldon RA. Wills JW. Characterization of a small (25-kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release. 1993 Sep. J Virol. 67(9):5550-61. National Cancer Institute Craven RC. Leure-duPree AE. Erdie CR. Wilson CB. Wills JW. Necessity of the spacer peptide between CA and NC in the Rous sarcoma virus gag protein. 1993 Oct. J Virol. 67(10):6246-52. National Cancer Institute Bennett RP. Nelle TD. Wills JW. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins. 1993 Nov. J Virol. 67(11):6487-98. National Cancer Institute Craven RC. Bennett RP. Wills JW. Role of the avian retroviral protease in the activation of reverse transcriptase during virion assembly. 1991 Nov. J Virol. 65(11):6205-17. National Cancer Institute Wills JW. Craven RC. Form, function, and use of retroviral gag proteins. 1991 Jun. AIDS. 5(6):639-54. National Cancer Institute Wills JW. Craven RC. Weldon RA. Nelle TD. Erdie CR. Suppression of retroviral MA deletions by the amino-terminal membrane-binding domain of p60src. 1991 Jul. J Virol. 65(7):3804-12. National Cancer Institute Bennett RP. Rhee S. Craven RC. Hunter E. Wills JW. Amino acids encoded downstream of gag are not required by Rous sarcoma virus protease during gag-mediated assembly. 1991 Jan. J Virol. 65(1):272-80. National Cancer Institute Weldon RA. Erdie CR. Oliver MG. Wills JW. Incorporation of chimeric gag protein into retroviral particles. 1990 Sep. J Virol. 64(9):4169-79. National Cancer Institute Erdie CR. Wills JW. Myristylation of Rous sarcoma virus Gag protein does not prevent replication in avian cells. 1990 Oct. J Virol. 64(10):5204-8. National Cancer Institute Wills JW. Craven RC. Achacoso JA. Creation and expression of myristylated forms of Rous sarcoma virus gag protein in mammalian cells. 1989 Oct. J Virol. 63(10):4331-43. National Cancer Institute Wills JW. Retro-secretion of recombinant proteins. 1989 Jul 27. Nature. 340(6231):323-4. Perez L. Wills JW. Hunter E. Expression of the Rous sarcoma virus env gene from a simian virus 40 late-region replacement vector: effects of upstream initiation codons. 1987 Apr. J Virol. 61(4):1276-81. National Cancer Institute Hardwick JM. Shaw KE. Wills JW. Hunter E. Amino-terminal deletion mutants of the Rous sarcoma virus glycoprotein do not block signal peptide cleavage but can block intracellular transport. 1986 Sep. J Cell Biol. 103(3):829-38. National Cancer Institute Wills JW. Troutman WB. Riggsby WS. Circular mitochondrial genome of Candida albicans contains a large inverted duplication. 1985 Oct. J Bacteriol. 164(1):7-13. National Institute of Allergy and Infectious Diseases National Institute of General Medical Sciences Barker CS. Wills JW. Bradac JA. Hunter E. Molecular cloning of the Mason-Pfizer monkey virus genome: characterization and cloning of subgenomic fragments. 1985 Apr 30. Virology. 142(2):223-40. National Cancer Institute Wills JW. Lasker BA. Sirotkin K. Riggsby WS. Repetitive DNA of Candida albicans: nuclear and mitochondrial components. 1984 Mar. J Bacteriol. 157(3):918-24. Wills JW. Srinivas RV. Hunter E. Mutations of the Rous sarcoma virus env gene that affect the transport and subcellular location of the glycoprotein products. 1984 Dec. J Cell Biol. 99(6):2011-23. National Cancer Institute Wills JW. Hardwick JM. Shaw K. Hunter E. Alterations in the transport and processing of Rous sarcoma virus envelope glycoproteins mutated in the signal and anchor regions. 1983. J Cell Biochem. 23(1-4):81-94. National Cancer Institute Riggsby WS. Torres-Bauza LJ. Wills JW. Townes TM. DNA content, kinetic complexity, and the ploidy question in Candida albicans. 1982 Jul. Mol Cell Biol. 2(7):853-62. National Institute of Allergy and Infectious Diseases National Institute of General Medical Sciences